Cinqair.com

Website Ranking Data
Current Alexa Rank

534,366

Updated Sep 30 2022
Historical Rank
Estimated Visitors

5,701

Daily Unique Visitors

176,723

Monthly Visitors

2,120,676

Yearly Visitors
Name Server Information
ns3.tevapharm.com
ns4.tevapharm.com
ns5.tevapharm.com
Web Server Information
IP Address 68.66.12.34
Server Response 200
Web Server Microsoft-IIS/8.5
Top related sites:
Meta Tags and Data
Title
CINQAIR.com – CINQAIR® (reslizumab) Injection now approved
Meta Description
CINQAIR® (reslizumab) Injection is now approved as an add-on treatment for adults (18 years and older) with severe asthma and elevated eosinophil levels
Meta Keywords
cinqair, syncair, reslizumab, asthma IV, asthma injection, severe asthma treatment, elevated eosinophil levels, elevated blood eosinophil levels, teva support solutions, cinqair financial assistance, IL-5 asthma treatment, anti-interleukin-5 treatment, cinqair prescribing information, cinqair patient information leaflet, eosinophilic phenotype
Technologies in use
Google Analytics, jQuery, Font Awesome
Server Response
Cache-Controlprivate
Content-Typetext/html; charset=utf-8
ServerMicrosoft-IIS/8.5
X-XSS-Protection1; mode=block
X-Frame-Optionssameorigin
X-Content-Type-Optionsnosniff
Content-Length28441